May Alattar, MD
Endocrinology · Bethesda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
- Since medical school
- 27 years
- Graduated 1999
Offices
6 locations · Johns Hopkins Community Physicians, Inc · Telemedicine Group PC
Hospitals listed: Johns Hopkins Howard County Medical Center · Sibley Memorial Hospital · Suburban Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Alattar’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Maryland D0068860Physician · since 2009 · expires 2028-09-30Specialty on the licence: DiabetesTold the state board they are board certified.ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Johns Hopkins Howard County Medical CenterColumbia, MDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Johns Hopkins Health System, which runs 6 hospitals in 3 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.35, Oct 2024 – Sep 2025
- Sibley Memorial HospitalWashington, DCAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Johns Hopkins Health System, which runs 6 hospitals in 3 statesPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.1 (11.1 to 15.6) · 849 cases, Jan 2024 – Dec 2024Better than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.68 (0.38 to 0.98), Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.287, Oct 2024 – Sep 2025
- Suburban HospitalBethesda, MDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Johns Hopkins Health System, which runs 6 hospitals in 3 statesPatients rate it 3 of 5 · 83% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.42, Oct 2024 – Sep 2025
See every measure and the patient survey for Johns Hopkins Howard County Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.35 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0.07 to 1.97) · 1,459 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.63 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 177.34 (119.83 to 234.84) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 243 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 218 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 749 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 806 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 321 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 3,338 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.36) · 10,983 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 11,012 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (2 to 6.15) · 1,305 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.55 (0 to 3.22) · 330 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.47) · 1,245 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.1 (0 to 16.32) · 335 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (1.22 to 9.18) · 308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.62 (0.06 to 1.17) · 9,340 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 65 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.352 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.475 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.746 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 147 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 751 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 12.1 · 818 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 4.1 · 811 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 700 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 272 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.1 to 18.2) · 59 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 735 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,340 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sibley Memorial Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.1 (11.1 to 15.6) · 849 cases | Worse | Jan 2024 – Dec 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.68 (0.38 to 0.98) | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.287 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.68 (0 to 1.56) · 1,497 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.59 (85.23 to 205.94) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.1 · 578 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 2,339 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0.01 to 0.42) · 6,274 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.09 to 0.48) · 6,360 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.83 (1.89 to 5.76) · 1,538 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.31 (0 to 2.85) · 915 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.26 (1.76 to 4.77) · 1,477 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 3.46 (0 to 9.65) · 836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.53 (1.28 to 7.77) · 821 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.56 (0.12 to 3.01) · 628 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.15 (0 to 0.81) · 5,634 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.7 · 86 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.047 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.248 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 2.27 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.609 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.455 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 25 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 294 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 11.2 · 369 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -16.7 · 575 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15 · 502 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (4.2 to 6.9) · 849 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 78 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.4 (8.7 to 14.8) · 1,341 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 799 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,797 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Suburban Hospital
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.42 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,489 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.13 (0.86 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 168.88 (123.16 to 214.6) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.6 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.3 · 244 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 787 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16 · 741 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 406 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 3,516 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.13 to 0.48) · 11,468 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,370 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.26 (1.48 to 5.05) · 2,478 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.34 (0 to 2.89) · 918 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.7 to 3.43) · 2,361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.58 (5.67 to 17.5) · 900 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.3 (1.78 to 8.83) · 909 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.57 (0.12 to 3.01) · 426 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.93 (0.42 to 1.43) · 10,088 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 143 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.819 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.318 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.243 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.812 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 717 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 40.6 · 284 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.6 · 883 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.2 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 648 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 122 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.6 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.4) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,085 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,819 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$19,921
Medicare paid this office $19,921 for 160 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 92 | $8,432 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,028 | $139 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,014 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $2,679 | $96 |
Who their Medicare patients are
160 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 15% · Women 57% · Also on Medicaid 26% · Health risk score 2.69. Above the middle of the specialty; the typical hospitalist clinician is at 2.49.
Conditions among them: High blood pressure 75% · Diabetes 75% · Chronic kidney disease 67% · Coronary heart disease 51% · Heart failure 51% · Atrial fibrillation 37% · Depression 35% · Stroke 34% · COPD 30% · Dementia 30% · Cancer 16%.
The office billed $60,780, Medicare allowed $25,379 and paid $19,921; for 232 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 160 | 232 | 75 | 2.69 | $60,780 | $19,921 |
| 2023 | 288 | 553 | 75 | 2.66 | $145,641 | $49,455 |
| 2022 | 47 | 72 | 72 | 1.67 | $18,267 | $5,827 |
| 2019 | 229 | 454 | 65 | 2.37 | $98,064 | $30,808 |
| 2018 | 234 | 526 | 65 | 2.68 | $113,445 | $35,188 |
| 2017 | 237 | 519 | 64 | 2.64 | $107,175 | $31,508 |
| 2016 | 215 | 449 | 64 | 2.28 | $91,470 | $27,052 |
| 2015 | 176 | 349 | 64 | 2.44 | $56,425 | $18,219 |
| 2014 | 153 | 328 | 63 | 2.83 | $40,942 | $16,339 |
| 2013 | 158 | 329 | 64 | 2.67 | $49,956 | $19,565 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 159 | $18,093 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $12,283 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $10,943 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 45 | $4,667 | $104 |
2022: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,797 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $958 | $60 |
2019: 7 services
| Return visit (30+ min) | 149 | $16,088 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,451 | $173 |
| Long return visit (40+ min) | 32 | $2,842 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,763 | $61 |
| New patient visit (45+ min) | 18 | $1,573 | $87 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $869 | $79 |
| Short return visit (20+ min) | 14 | $610 | $41 |
2018: 6 services
| Return visit (30+ min) | 150 | $15,534 | $58 |
| Long return visit (40+ min) | 53 | $5,428 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $4,138 | $58 |
| New patient visit (45+ min) | 28 | $2,690 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,252 | $102 |
| Short return visit (20+ min) | 12 | $587 | $42 |
2017: 6 services
| Return visit (30+ min) | 136 | $16,130 | $57 |
| Long return visit (40+ min) | 31 | $3,075 | $85 |
| New patient visit (45+ min) | 30 | $2,902 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,892 | $111 |
| Short return visit (20+ min) | 51 | $2,510 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,172 | $59 |
2016: 8 services
| Return visit (30+ min) | 127 | $14,896 | $59 |
| Short return visit (20+ min) | 58 | $2,740 | $38 |
| New patient visit (45+ min) | 22 | $2,217 | $101 |
| Long return visit (40+ min) | 20 | $1,991 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,563 | $112 |
| New patient visit (30+ min) | 14 | $747 | $53 |
| Fine needle aspiration using imaging guidance | 13 | $653 | $50 |
| Ultrasonic guidance for needle placement | 13 | $329 | $25 |
2015: 5 services
| Return visit (30+ min) | 65 | $6,229 | $61 |
| Short return visit (20+ min) | 93 | $5,858 | $38 |
| New patient visit (45+ min) | 18 | $1,829 | $102 |
| New patient visit (30+ min) | 25 | $1,465 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,192 | $60 |
2014: 5 services
| Short return visit (20+ min) | 84 | $5,784 | $37 |
| Return visit (30+ min) | 42 | $3,593 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,147 | $60 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,603 | $84 |
| New patient visit (30+ min) | 22 | $1,246 | $57 |
2013: 5 services
| Return visit (30+ min) | 48 | $4,824 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $4,179 | $58 |
| Short return visit (20+ min) | 57 | $3,067 | $40 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 28 | $2,566 | $83 |
| New patient visit (30+ min) | 30 | $1,850 | $62 |
Medicaid work
$675 in 2023
Medicaid paid $675 for 15 billed services this clinician did in 2023, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 15 | $675 |
| 2023 | 15 | 1 | 13 | $675 |
| 2021 | 12 | 1 | 12 | $1,029 |
| 2020 | 33 | 1 | 16 | $1,508 |
| 2019 | 195 | 1 | 29 | $983 |
| 2018 | 183 | 1 | 24 | $0 |
See the largest Medicaid services in earlier years
2021
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $1,029 |
2020
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 33 | $1,508 |
2019
| Return visit (30+ min) | 195 | $983 |
2018
| Return visit (30+ min) | 183 | $0 |
Drugs they prescribed that Part D paid
$79,642
Pharmacies billed $79,642 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 114) in 2024. At or below the middle of the specialty; the typical hospitalist clinician is at 4%.
0 generic and 71 brand-name prescriptions · $79,642 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 24 | $32,242 | $1,343 |
Year by year
| 2024 | 114 | 47 | 0% (0) | 62% | $79,642 |
| 2023 | 413 | 200 | 0% (0) | 40% | $103,629 |
| 2022 | 1,679 | 389 | None | 36% | $401,988 |
| 2021 | 1,300 | 327 | None | 33% | $265,907 |
| 2020 | 1,070 | 314 | None | 35% | $209,426 |
| 2019 | 1,700 | 219 | None | 46% | $546,214 |
| 2018 | 1,702 | 192 | None | 45% | $594,839 |
| 2017 | 1,627 | 184 | 1% (14) | 45% | $541,731 |
| 2016 | 1,356 | 169 | 1% (15) | 49% | $479,054 |
| 2015 | 1,027 | 114 | 2% (18) | 46% | $273,826 |
| 2014 | 846 | 103 | None | 49% | $225,319 |
| 2013 | 575 | 80 | None | 47% | $104,199 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Jardiance | 16 | $10,059 | $629 |
| Lantus Solostar | 19 | $6,011 | $316 |
| Humalog Kwikpen U-100 | 17 | $5,437 | $320 |
| Humalog | 13 | $4,010 | $308 |
| Lantus | 12 | $3,136 | $261 |
| Humulin 70/30 Kwikpen | 11 | $2,974 | $270 |
| Levothyroxine | 96 | $2,288 | $24 |
| Cinacalcet | 13 | $491 | $38 |
| Methimazole | 25 | $488 | $20 |
| Ultra-Fine Short Pen Needle | 20 | $401 | $20 |
| Alendronate | 15 | $166 | $11 |
2022: 32 drugs
| Humulin R U-500 Kwikpen | 68 | $81,725 | $1,202 |
| Jardiance | 86 | $52,152 | $606 |
| Ozempic | 31 | $44,486 | $1,435 |
| Humalog Kwikpen U-100 | 62 | $20,410 | $329 |
| Trulicity | 11 | $18,554 | $1,687 |
| Humalog | 43 | $15,510 | $361 |
| Omnipod Dash Pods (Gen 4) | 17 | $15,004 | $883 |
| Victoza 2-Pak | 23 | $14,760 | $642 |
| Tradjenta | 18 | $13,801 | $767 |
| Humulin 70/30 Kwikpen | 35 | $10,805 | $309 |
| Lantus | 34 | $10,748 | $316 |
| Lantus Solostar | 37 | $10,163 | $275 |
| Levothyroxine | 335 | $7,687 | $23 |
| Baqsimi | 11 | $5,809 | $528 |
| Humulin R | 36 | $4,102 | $114 |
| Methimazole | 193 | $3,671 | $19 |
| Testosterone | 23 | $3,040 | $132 |
| Humulin N | 14 | $2,839 | $203 |
| Cinacalcet | 64 | $2,451 | $38 |
| Armour Thyroid | 19 | $1,927 | $101 |
| Liothyronine | 26 | $1,768 | $68 |
| Hydrocortisone | 23 | $1,616 | $70 |
| Calcitriol | 20 | $1,287 | $64 |
| Ultra-Fine Short Pen Needle | 42 | $847 | $20 |
| NP Thyroid | 12 | $845 | $70 |
| Alendronate | 62 | $676 | $11 |
| Sure Comfort Pen Needle | 13 | $511 | $39 |
| Insulin | 16 | $491 | $31 |
| Insulin | 19 | $352 | $19 |
| Insulin | 13 | $284 | $22 |
| Propranolol | 11 | $240 | $22 |
| Glipizide | 16 | $146 | $9 |
2021: 22 drugs
| Humulin R U-500 Kwikpen | 44 | $58,636 | $1,333 |
| Ozempic | 19 | $21,222 | $1,117 |
| Humalog Kwikpen U-100 | 47 | $14,985 | $319 |
| Jardiance | 25 | $14,532 | $581 |
| Lantus Solostar | 32 | $10,519 | $329 |
| Levothyroxine | 273 | $6,386 | $23 |
| Lantus | 18 | $5,892 | $327 |
| Humalog | 26 | $4,952 | $190 |
| Humulin 70/30 Kwikpen | 34 | $3,940 | $116 |
| Methimazole | 169 | $3,458 | $20 |
| Hydrocortisone | 39 | $2,784 | $71 |
| Cinacalcet | 52 | $2,513 | $48 |
| Testosterone | 15 | $2,389 | $159 |
| Humulin N Kwikpen | 14 | $1,873 | $134 |
| Humulin N | 20 | $1,821 | $91 |
| Armour Thyroid | 16 | $1,612 | $101 |
| Bromocriptine Mesylate | 11 | $1,474 | $134 |
| Ultra-Fine Short Pen Needle | 54 | $1,102 | $20 |
| Calcitriol | 14 | $834 | $60 |
| Depo-Testosterone | 13 | $802 | $62 |
| Alendronate | 59 | $588 | $10 |
| Insulin | 12 | $196 | $16 |
2020: 17 drugs
| Humulin R U-500 Kwikpen | 59 | $37,926 | $643 |
| Cinacalcet | 64 | $17,047 | $266 |
| Humalog | 38 | $14,032 | $369 |
| Lantus Solostar | 22 | $11,797 | $536 |
| Novolog Mix 70-30 Flexpen | 16 | $9,997 | $625 |
| Jardiance | 17 | $9,206 | $542 |
| Humalog Kwikpen U-100 | 24 | $7,134 | $297 |
| Lantus | 19 | $6,618 | $348 |
| Levothyroxine | 207 | $5,710 | $28 |
| Humulin 70/30 Kwikpen | 23 | $3,265 | $142 |
| Methimazole | 120 | $2,641 | $22 |
| Hydrocortisone | 26 | $1,292 | $50 |
| Ultra-Fine Short Pen Needle | 35 | $887 | $25 |
| Sure Comfort | 17 | $825 | $49 |
| Calcitriol | 11 | $430 | $39 |
| Alendronate | 22 | $216 | $10 |
| Metformin Hcl Er | 11 | $168 | $15 |
2019: 45 drugs
| Trulicity | 96 | $97,512 | $1,016 |
| Humulin R U-500 Kwikpen | 63 | $63,291 | $1,005 |
| Androgel | 13 | $23,280 | $1,791 |
| Basaglar Kwikpen U-100 | 55 | $22,465 | $408 |
| Lantus Solostar | 45 | $21,036 | $467 |
| Levemir Flextouch | 42 | $18,029 | $429 |
| Tradjenta | 41 | $15,695 | $383 |
| Novolog Mix 70-30 Flexpen | 21 | $15,455 | $736 |
| Toujeo Solostar | 26 | $15,331 | $590 |
| Novolog Flexpen | 29 | $14,860 | $512 |
| Lyrica | 20 | $14,735 | $737 |
| Januvia | 18 | $14,672 | $815 |
| Novolog | 20 | $13,976 | $699 |
| Ozempic | 14 | $13,758 | $983 |
| Cinacalcet | 13 | $12,977 | $998 |
| Jardiance | 15 | $10,890 | $726 |
| Tresiba Flextouch U-100 | 13 | $7,841 | $603 |
| Androderm | 12 | $7,377 | $615 |
| Levothyroxine | 144 | $2,431 | $17 |
| Desmopressin Acetate | 12 | $2,182 | $182 |
| Ultra-Fine Short Pen Needle | 35 | $1,619 | $46 |
| Ultra-Fine Nano Pen Needle | 22 | $1,579 | $72 |
| Ultra-Fine Mini Pen Needle | 25 | $1,336 | $53 |
| Rosuvastatin | 34 | $1,194 | $35 |
| Comfort Ez Pen Needle | 20 | $1,177 | $59 |
| Alcohol Prep Pads | 15 | $821 | $55 |
| Glipizide Er | 34 | $813 | $24 |
| Metformin | 73 | $601 | $8 |
| Pravastatin | 25 | $549 | $22 |
| Methimazole | 31 | $501 | $16 |
| Liothyronine | 12 | $444 | $37 |
| Easy Touch Pen Needle | 12 | $341 | $28 |
| Calcitriol | 28 | $338 | $12 |
| Metformin Hcl Er | 33 | $334 | $10 |
| Atorvastatin | 17 | $287 | $17 |
| Gabapentin | 27 | $181 | $7 |
| Carvedilol | 11 | $166 | $15 |
| Amlodipine Besylate | 23 | $138 | $6 |
| Lisinopril | 18 | $135 | $8 |
| Glimepiride | 26 | $133 | $5 |
| Losartan-Hydrochlorothiazide | 24 | $101 | $4 |
| Omeprazole | 12 | $62 | $5 |
| Alendronate | 11 | $61 | $6 |
| Hydrochlorothiazide | 14 | $53 | $4 |
| Furosemide | 12 | $38 | $3 |
2018: 50 drugs
| Humulin R U-500 Kwikpen | 82 | $69,378 | $846 |
| Trulicity | 58 | $54,663 | $942 |
| Androgel | 28 | $32,406 | $1,157 |
| Humulin R U-500 | 17 | $26,505 | $1,559 |
| Tradjenta | 46 | $22,061 | $480 |
| Januvia | 32 | $21,186 | $662 |
| Levemir Flextouch | 46 | $20,394 | $443 |
| Lantus Solostar | 43 | $19,220 | $447 |
| Toujeo Solostar | 34 | $17,556 | $516 |
| Basaglar Kwikpen U-100 | 34 | $17,489 | $514 |
| Novolog Flexpen | 31 | $17,232 | $556 |
| Sensipar | 21 | $16,983 | $809 |
| Lyrica | 27 | $15,394 | $570 |
| Victoza 3-Pak | 14 | $13,269 | $948 |
| Novolog | 16 | $12,223 | $764 |
| Humalog Kwikpen U-100 | 17 | $11,901 | $700 |
| Lantus | 11 | $8,808 | $801 |
| Androderm | 11 | $7,211 | $656 |
| Humalog | 11 | $6,413 | $583 |
| Cabergoline | 15 | $5,343 | $356 |
| Tresiba Flextouch U-100 | 11 | $3,971 | $361 |
| Levothyroxine | 126 | $2,490 | $20 |
| Ultra-Fine Mini Pen Needle | 39 | $1,946 | $50 |
| Comfort Ez Pen Needle | 26 | $1,771 | $68 |
| Rosuvastatin | 24 | $1,319 | $55 |
| Synthroid | 15 | $1,278 | $85 |
| Ultra-Fine Nano Pen Needle | 16 | $1,143 | $71 |
| Pravastatin | 36 | $1,002 | $28 |
| Liothyronine | 13 | $848 | $65 |
| Metoprolol | 16 | $832 | $52 |
| Insulin | 14 | $733 | $52 |
| Pen Needle | 13 | $725 | $56 |
| Fenofibrate | 12 | $526 | $44 |
| Calcitriol | 32 | $504 | $16 |
| Metformin | 71 | $444 | $6 |
| Atorvastatin | 24 | $382 | $16 |
| Metformin Hcl Er | 41 | $351 | $9 |
| Lidocaine | 11 | $344 | $31 |
| Gabapentin | 24 | $268 | $11 |
| Amlodipine Besylate | 62 | $265 | $4 |
| Methimazole | 24 | $240 | $10 |
| Glipizide Er | 15 | $219 | $15 |
| Unifine Pentips | 11 | $181 | $16 |
| Losartan | 15 | $164 | $11 |
| Hydrochlorothiazide | 18 | $138 | $8 |
| Lisinopril | 22 | $125 | $6 |
| Carvedilol | 13 | $103 | $8 |
| Metoprolol | 12 | $66 | $5 |
| Losartan-Hydrochlorothiazide | 11 | $48 | $4 |
| Glimepiride | 20 | $47 | $2 |
2017: 42 drugs
| Humulin R U-500 Kwikpen | 73 | $71,977 | $986 |
| Levemir Flextouch | 68 | $32,816 | $483 |
| Metformin Hcl Er | 43 | $30,636 | $712 |
| Lantus Solostar | 59 | $29,630 | $502 |
| Humulin R U-500 | 17 | $24,836 | $1,461 |
| Androgel | 31 | $23,115 | $746 |
| Sensipar | 21 | $21,969 | $1,046 |
| Novolog Flexpen | 38 | $21,554 | $567 |
| Victoza 3-Pak | 17 | $17,591 | $1,035 |
| Humalog Kwikpen U-100 | 27 | $17,522 | $649 |
| Tradjenta | 42 | $17,143 | $408 |
| Lyrica | 28 | $15,880 | $567 |
| Januvia | 21 | $15,327 | $730 |
| Lantus | 20 | $11,941 | $597 |
| Novolog | 14 | $11,480 | $820 |
| Androderm | 21 | $10,312 | $491 |
| Toujeo Solostar | 20 | $8,276 | $414 |
| Cabergoline | 12 | $7,019 | $585 |
| Humalog | 13 | $3,879 | $298 |
| Levothyroxine | 114 | $2,492 | $22 |
| Ultra-Fine Mini Pen Needle | 33 | $1,807 | $55 |
| Pen Needles | 26 | $1,533 | $59 |
| Pravastatin | 60 | $1,195 | $20 |
| Comfort Ez | 18 | $1,134 | $63 |
| Liothyronine | 19 | $1,121 | $59 |
| Metformin | 84 | $854 | $10 |
| Insulin | 15 | $694 | $46 |
| Ultra-Fine Short Pen Needle | 13 | $667 | $51 |
| Bd Ultra-Fine Pen Needle | 12 | $559 | $47 |
| Ultra-Fine Nano Pen Needle | 11 | $524 | $48 |
| Glimepiride | 32 | $388 | $12 |
| Glipizide Er | 23 | $328 | $14 |
| Atorvastatin | 20 | $325 | $16 |
| Calcitriol | 27 | $295 | $11 |
| Lisinopril | 39 | $287 | $7 |
| Methimazole | 24 | $277 | $12 |
| Unifine Pentips | 15 | $267 | $18 |
| Losartan-Hydrochlorothiazide | 17 | $226 | $13 |
| Amlodipine Besylate | 40 | $166 | $4 |
| Gabapentin | 12 | $141 | $12 |
| Hydrochlorothiazide | 15 | $105 | $7 |
| Metoprolol | 15 | $85 | $6 |
2016: 39 drugs
| Metformin Hcl Er | 14 | $48,821 | $3,487 |
| Levemir Flextouch | 56 | $36,295 | $648 |
| Humulin R U-500 | 26 | $33,727 | $1,297 |
| Humulin R U-500 Kwikpen | 26 | $29,494 | $1,134 |
| Januvia | 41 | $22,705 | $554 |
| Novolog Flexpen | 33 | $21,411 | $649 |
| Lantus Solostar | 51 | $20,772 | $407 |
| Humalog | 31 | $19,439 | $627 |
| Tradjenta | 36 | $15,853 | $440 |
| Lantus | 34 | $15,357 | $452 |
| Victoza 3-Pak | 13 | $13,430 | $1,033 |
| Lyrica | 29 | $11,967 | $413 |
| Victoza 2-Pak | 15 | $11,896 | $793 |
| Novolog | 17 | $10,646 | $626 |
| Humalog Kwikpen U-100 | 20 | $10,637 | $532 |
| Novolog Mix 70-30 Flexpen | 12 | $9,725 | $810 |
| Androgel | 18 | $9,601 | $533 |
| Crestor | 17 | $5,736 | $337 |
| Cabergoline | 11 | $2,539 | $231 |
| Bd Ultra-Fine Pen Needle | 38 | $1,939 | $51 |
| Levothyroxine | 99 | $1,848 | $19 |
| Esomeprazole Magnesium | 18 | $1,667 | $93 |
| Alcohol Prep Pads | 20 | $839 | $42 |
| Synthroid | 11 | $547 | $50 |
| Pen Needles | 12 | $541 | $45 |
| Metformin | 82 | $539 | $7 |
| Liothyronine | 15 | $534 | $36 |
| Glipizide Xl | 17 | $354 | $21 |
| Gabapentin | 15 | $353 | $24 |
| Atorvastatin | 22 | $299 | $14 |
| Glimepiride | 26 | $295 | $11 |
| Insulin | 11 | $288 | $26 |
| Methimazole | 24 | $243 | $10 |
| Pravastatin | 13 | $236 | $18 |
| Hydrochlorothiazide | 25 | $173 | $7 |
| Lisinopril | 22 | $149 | $7 |
| Losartan-Hydrochlorothiazide | 14 | $132 | $9 |
| Metoprolol | 12 | $69 | $6 |
| Amlodipine Besylate | 14 | $42 | $3 |
2015: 25 drugs
| Levemir Flextouch | 45 | $30,327 | $674 |
| Humulin R U-500 | 20 | $23,382 | $1,169 |
| Januvia | 47 | $18,967 | $404 |
| Novolog Flexpen | 26 | $17,419 | $670 |
| Lantus | 28 | $13,910 | $497 |
| Tradjenta | 26 | $11,428 | $440 |
| Lantus Solostar | 24 | $10,681 | $445 |
| Victoza 2-Pak | 16 | $8,692 | $543 |
| Crestor | 17 | $5,699 | $335 |
| Androderm | 11 | $4,545 | $413 |
| Novolog | 13 | $4,033 | $310 |
| Levemir | 14 | $3,622 | $259 |
| Bd Ultra-Fine Pen Needle | 36 | $1,669 | $46 |
| Esomeprazole Magnesium | 19 | $1,590 | $84 |
| Levothyroxine | 51 | $954 | $19 |
| Atorvastatin | 38 | $350 | $9 |
| Metformin | 44 | $275 | $6 |
| Gabapentin | 18 | $274 | $15 |
| Glimepiride | 21 | $259 | $12 |
| Hydrochlorothiazide | 24 | $208 | $9 |
| Metformin Hcl Er | 30 | $191 | $6 |
| Simvastatin | 20 | $150 | $7 |
| Methimazole | 14 | $149 | $11 |
| Tamsulosin | 11 | $137 | $12 |
| Omeprazole | 14 | $107 | $8 |
2014: 26 drugs
| Somatuline Depot | 12 | $46,569 | $3,881 |
| Humalog | 40 | $26,975 | $674 |
| Lantus Solostar | 25 | $16,585 | $663 |
| Novolog Flexpen | 24 | $15,289 | $637 |
| Lantus | 27 | $12,929 | $479 |
| Januvia | 33 | $12,504 | $379 |
| Trelstar | 11 | $9,141 | $831 |
| Novolog | 32 | $8,241 | $258 |
| Levemir | 16 | $6,268 | $392 |
| Humulin N | 16 | $5,528 | $345 |
| Crestor | 17 | $3,551 | $209 |
| Zetia | 11 | $2,408 | $219 |
| Bd Ultra-Fine Pen Needle | 39 | $1,897 | $49 |
| Metformin Hcl Er | 14 | $1,052 | $75 |
| Insulin | 23 | $872 | $38 |
| Atorvastatin | 42 | $709 | $17 |
| Metformin | 37 | $310 | $8 |
| Metoprolol | 11 | $276 | $25 |
| Levothyroxine | 18 | $258 | $14 |
| Glimepiride | 26 | $247 | $10 |
| Hydrochlorothiazide | 13 | $149 | $11 |
| Simvastatin | 14 | $140 | $10 |
| Amlodipine Besylate | 27 | $129 | $5 |
| Gabapentin | 11 | $117 | $11 |
| Losartan | 15 | $78 | $5 |
| Losartan-Hydrochlorothiazide | 12 | $47 | $4 |
2013: 18 drugs
| Humalog | 31 | $16,273 | $525 |
| Lantus | 29 | $12,063 | $416 |
| Lantus Solostar | 30 | $10,268 | $342 |
| Januvia | 22 | $9,386 | $427 |
| Novolog | 25 | $7,500 | $300 |
| Humulin N | 14 | $6,409 | $458 |
| Novolog Mix 70-30 | 12 | $5,505 | $459 |
| Atorvastatin | 36 | $1,513 | $42 |
| Bd Ultra-Fine Pen Needle | 29 | $1,141 | $39 |
| Synthroid | 14 | $434 | $31 |
| Insulin | 13 | $341 | $26 |
| Metformin | 29 | $309 | $11 |
| Simvastatin | 27 | $267 | $10 |
| Glimepiride | 11 | $230 | $21 |
| Levothyroxine | 17 | $211 | $12 |
| Lisinopril | 13 | $202 | $16 |
| Pantoprazole | 13 | $63 | $5 |
| Amlodipine Besylate | 14 | $62 | $4 |
Money from drug and device companies
$172 in 2019
A payment is not proof that care is biased.
| Mannkind | Afrezza | $114 | 1 payment
|
| Novo Nordisk | Ozempic | $24 | 1 payment
|
| Lilly USA | Baqsimi | $18 | 1 payment
|
| Insulet | Omnipod | $15 | 1 payment
|
See all 4 published payments
| Insulet | Meals · 2019-09-20 | Omnipod | $15 |
| Lilly USA | Meals · 2019-08-14 | Baqsimi | $18 |
| Mannkind | Meals · 2019-05-22 | Afrezza | $114 |
| Novo Nordisk | Meals · 2019-03-26 | Ozempic | $24 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1154523371
- Licence
- MD D68860Maryland D0068860: Active
- Group
- Johns Hopkins Community Physicians, Inc · Telemedicine Group PC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- MD 054823500
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 3400 Douglas Blvd Ste 225, Roseville, CA, 95661
- NPI first listed
- 2007-06-01
- NPI last updated
- 2025-04-22
- NPI record certified
- 2025-04-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 750 Lexington Ave, New York, NY, 10022 · 3400 Douglas Blvd Ste 170, Roseville, CA, 95661
This office lists an electronic records connection.